Related Experiment Video
Updated: Jun 12, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Type 1 diabetes in children - emergency management
Aris Siafarikas1, Susan O'Connell
1Department of Endocrinology and Diabetes, Princess Margaret Hospital, Perth, Western Australia, Australia. aris.siafarikas@health.wa.gov.au
Australian Family Physician
|May 21, 2010
Summary
Early recognition and management of diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) are crucial. Prompt assessment with urinalysis, blood glucose, and ketone tests can prevent severe complications and fatalities.
Area of Science:
- Endocrinology
- Diabetology
- Emergency Medicine
Background:
- Type 1 diabetes mellitus (T1DM) diagnosis frequently involves presentation with diabetic ketoacidosis (DKA), a serious complication.
- DKA is a leading cause of mortality in diabetes, primarily due to cerebral edema.
- Most patients with new-onset T1DM and DKA initially consult general practitioners.
Purpose of the Study:
- To enhance early DKA recognition in non-specialist settings.
- To provide guidelines for initial DKA management prior to specialist transfer.
Main Methods:
- Review of current literature on T1DM, DKA presentation, and management.
- Synthesis of evidence for early diagnostic markers and initial treatment protocols.
Main Results:
- Increased awareness of early symptoms like polyuria and polydipsia improves DKA recognition.
- Urinalysis, fingerprick blood glucose, and ketone measurements are vital for early assessment.
- Risk factor identification aids in proactive DKA evaluation.
Conclusions:
- Early symptom recognition and diagnostic testing are key to minimizing DKA severity.
- Prompt referral to specialist centers is essential for suspected new-onset T1DM/DKA.
- Standardized initial management in non-specialist settings improves patient outcomes before transfer.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...